Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics

PHILADELPHIA, Jan. 5, 2022 /PRNewswire/ — Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, has entered into an agreement to leverage Alloy Therapeutics’ transgenic humanized ATX-Gx™ mice as an added strategy to rapidly isolate fully human…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.